Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 4 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Lymphoma 1 HTLV-I Infections 1 Glioma 1

Interventions

trametinib 2 dabrafenib 2 perampanel 1 olutasidenib 1 Valproic Acid 1 Temozolomide 1 Restraint, Physical 1 Outcome Assessment, Health Care 1 Observational Studies as Topic 1 Levetiracetam 1 Cytochrome P-450 CYP3A 1 Cytochrome P-450 CYP2C9 1 Cytochrome P-450 CYP2C8 1 Cytochrome P-450 CYP2C19 1 Cytochrome P-450 CYP2B6 1 Cytochrome P-450 CYP1A2 1 Anticonvulsants 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Glioma × Valproic Acid × Clear all

NCT03048084 2025-02-04

STING

Leiden University Medical Center

Phase 4 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡